APA

Cataldo A., Piovan C., Plantamura I., D'Ippolito E., Camelliti S., Casalini P., Giussani M., Déas O., Cairo S., Judde J., Tagliabue E. & Iorio M. V. (2018). MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab. : Oncotarget.

Chicago

Cataldo Alessandra, Piovan Claudia, Plantamura Ilaria, D'Ippolito Elvira, Camelliti Simone, Casalini Patrizia, Giussani Marta, Déas Olivier, Cairo Stefano, Judde Jean-Gabriel, Tagliabue Elda and Iorio Marilena V. 2018. MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab. : Oncotarget.

Harvard

Cataldo A., Piovan C., Plantamura I., D'Ippolito E., Camelliti S., Casalini P., Giussani M., Déas O., Cairo S., Judde J., Tagliabue E. and Iorio M. V. (2018). MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab. : Oncotarget.

MLA

Cataldo Alessandra, Piovan Claudia, Plantamura Ilaria, D'Ippolito Elvira, Camelliti Simone, Casalini Patrizia, Giussani Marta, Déas Olivier, Cairo Stefano, Judde Jean-Gabriel, Tagliabue Elda and Iorio Marilena V. MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab. : Oncotarget. 2018.